News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,976 Results
Type
Article (86730)
Company Profile (653)
Press Release (761585)
Multimedia
Podcasts (154)
Webinars (20)
Section
Business (232566)
Career Advice (4132)
Deals (39763)
Drug Delivery (127)
Drug Development (90982)
Employer Resources (199)
FDA (18143)
Job Trends (17370)
News (396332)
Policy (39791)
Tag
Academia (2996)
Academic (1)
Accelerated approval (14)
Adcomms (30)
Allergies (104)
Alliances (56873)
ALS (115)
Alzheimer's disease (1587)
Antibody-drug conjugate (ADC) (177)
Approvals (18120)
Artificial intelligence (330)
Autoimmune disease (36)
Automation (17)
Bankruptcy (405)
Best Places to Work (12564)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (449)
Bladder cancer (95)
Brain cancer (38)
Breast cancer (355)
Cancer (2893)
Cardiovascular disease (204)
Career advice (3541)
Career pathing (34)
CAR-T (204)
CDC (30)
Cell therapy (554)
Cervical cancer (22)
Clinical research (74110)
Collaboration (1075)
Company closure (3)
Compensation (688)
Complete response letters (41)
COVID-19 (2880)
CRISPR (65)
C-suite (360)
Cystic fibrosis (116)
Data (2999)
Decentralized trials (2)
Denatured (55)
Depression (64)
Diabetes (281)
Diagnostics (6850)
Digital health (11)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (160)
Drug pricing (141)
Drug shortages (24)
Duchenne muscular dystrophy (161)
Earnings (97143)
Editorial (47)
Employer branding (25)
Employer resources (169)
Events (130507)
Executive appointments (811)
FDA (19793)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (883)
Gene editing (135)
Generative AI (29)
Gene therapy (427)
GLP-1 (848)
Government (5244)
Grass and pollen (6)
Guidances (254)
Healthcare (20799)
HIV (34)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (185)
Immuno-oncology (15)
Indications (40)
Infectious disease (3042)
Inflammatory bowel disease (166)
Inflation Reduction Act (13)
Influenza (64)
Intellectual property (121)
Interviews (813)
IPO (17818)
IRA (53)
Job creations (5193)
Job search strategy (2863)
Kidney cancer (14)
Labor market (61)
Layoffs (596)
Leadership (26)
Legal (10099)
Liver cancer (79)
Longevity (11)
Lung cancer (413)
Lymphoma (212)
Machine learning (13)
Management (65)
Manufacturing (437)
MASH (103)
Medical device (14408)
Medtech (14415)
Mergers & acquisitions (22522)
Metabolic disorders (818)
Multiple sclerosis (98)
NASH (23)
Neurodegenerative disease (155)
Neuropsychiatric disorders (35)
Neuroscience (2312)
NextGen: Class of 2025 (7672)
Non-profit (5073)
Now hiring (51)
Obesity (419)
Opinion (293)
Ovarian cancer (100)
Pain (112)
Pancreatic cancer (107)
Parkinson's disease (187)
Partnered (21)
Patents (305)
Patient recruitment (170)
Peanut (52)
People (65537)
Pharmaceutical (134)
Pharmacy benefit managers (21)
Phase I (22892)
Phase II (32226)
Phase III (24218)
Pipeline (1817)
Policy (237)
Postmarket research (3546)
Preclinical (10342)
Press Release (72)
Prostate cancer (143)
Psychedelics (42)
Radiopharmaceuticals (265)
Rare diseases (515)
Real estate (7394)
Recruiting (76)
Regulatory (27103)
Reports (59)
Research institute (2653)
Resumes & cover letters (650)
Rett syndrome (7)
RNA editing (13)
RSV (47)
Schizophrenia (97)
Series A (157)
Series B (105)
Service/supplier (25)
Sickle cell disease (63)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (37)
Startups (4305)
State (2)
Stomach cancer (12)
Supply chain (69)
Tariffs (71)
The Weekly (97)
Vaccines (861)
Venture capital (60)
Weight loss (275)
Women's health (45)
Worklife (20)
Date
Today (1)
Last 7 days (657)
Last 30 days (1897)
Last 365 days (28280)
2025 (17258)
2024 (35396)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1275)
Alabama (69)
Alaska (6)
Arizona (256)
Arkansas (9)
Asia (50437)
Australia (8876)
California (7233)
Canada (2268)
China (712)
Colorado (256)
Connecticut (293)
Delaware (187)
Europe (115583)
Florida (1020)
Georgia (214)
Hawaii (3)
Idaho (64)
Illinois (650)
India (30)
Indiana (337)
Iowa (17)
Japan (224)
Kansas (118)
Kentucky (26)
Louisiana (15)
Maine (58)
Maryland (1057)
Massachusetts (5615)
Michigan (213)
Minnesota (388)
Mississippi (3)
Missouri (76)
Montana (26)
Nebraska (26)
Nevada (77)
New Hampshire (54)
New Jersey (2113)
New Mexico (29)
New York (1990)
North Carolina (1197)
North Dakota (10)
Northern California (3184)
Ohio (207)
Oklahoma (14)
Oregon (45)
Pennsylvania (1557)
Puerto Rico (18)
Rhode Island (32)
South America (1653)
South Carolina (11)
South Dakota (1)
Southern California (2763)
Tennessee (75)
Texas (1031)
United States (26876)
Utah (154)
Virginia (193)
Washington D.C. (66)
Washington State (651)
West Virginia (3)
Wisconsin (59)
848,976 Results for "sk bio pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital
June 2, 2025
·
6 min read
Press Releases
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
May 30, 2025
·
7 min read
Press Releases
Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement
May 14, 2025
·
6 min read
Press Releases
Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions
May 16, 2025
·
10 min read
Press Releases
bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital
May 27, 2025
·
5 min read
Press Releases
Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital
May 9, 2025
·
8 min read
Press Releases
Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio
May 6, 2025
·
11 min read
Press Releases
SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate
July 18, 2025
·
3 min read
Press Releases
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
February 24, 2025
·
11 min read
Press Releases
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine
May 21, 2025
·
4 min read
1 of 84,898
Next
